Skip to main content
Erschienen in: Archives of Virology 11/2014

01.11.2014 | Original Article

Genomic and phylogenetic characterization of Shuni virus

verfasst von: Charmaine van Eeden, Frank Harders, Jeroen Kortekaas, Alex Bossers, Marietjie Venter

Erschienen in: Archives of Virology | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Shuni virus (SHUV), a member of the genus Orthobunyavirus, has in a recent study been associated with neurological disease in horses in South Africa. After its first isolation in 1966 from an asymptomatic bovine, very little attention was given to the genetic characterisation of SHUV. The association of SHUV with severe neurological disease in several horses in South Africa prompted us to determine the full genome sequence of a horse neurovirulent isolate to compare it to other members of the genus Orthobunyavirus, as well as the partially sequenced genome of the prototype SHUV strain. The availability of a full genome sequence will facilitate the development of a reverse genetics system to study SHUV molecular biology and pathogenesis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Moore DL et al (1975) Arthropod-borne viral infections in man in Nigeria: 1964-1970. Ann Trop Med Parasitol 69:49–64PubMed Moore DL et al (1975) Arthropod-borne viral infections in man in Nigeria: 1964-1970. Ann Trop Med Parasitol 69:49–64PubMed
2.
Zurück zum Zitat Causey OR et al (1972) Isolations of Simbu-group viruses in Ibadan, Nigeria 1964-69, including the new types Sango, Shamonda, Sabo and Shuni. Ann Trop Med Parasitol 66(3):357–362PubMed Causey OR et al (1972) Isolations of Simbu-group viruses in Ibadan, Nigeria 1964-69, including the new types Sango, Shamonda, Sabo and Shuni. Ann Trop Med Parasitol 66(3):357–362PubMed
5.
6.
Zurück zum Zitat Fazakerley JK et al (1988) Organization of the middle RNA segment of snowshoe hare Bunyavirus. Virology 167(2):422–432PubMedCrossRef Fazakerley JK et al (1988) Organization of the middle RNA segment of snowshoe hare Bunyavirus. Virology 167(2):422–432PubMedCrossRef
7.
Zurück zum Zitat Fuller F, Bhown AS, Bishop DH (1983) Bunyavirus nucleoprotein, N, and a non-structural protein, NSS, are coded by overlapping reading frames in the S RNA. J Gen Virol 64(Pt 8):1705–1714PubMedCrossRef Fuller F, Bhown AS, Bishop DH (1983) Bunyavirus nucleoprotein, N, and a non-structural protein, NSS, are coded by overlapping reading frames in the S RNA. J Gen Virol 64(Pt 8):1705–1714PubMedCrossRef
8.
Zurück zum Zitat Saeed MF et al (2001) Phylogeny of the Simbu serogroup of the genus Bunyavirus. J Gen Virol 82:2173–2181PubMed Saeed MF et al (2001) Phylogeny of the Simbu serogroup of the genus Bunyavirus. J Gen Virol 82:2173–2181PubMed
9.
Zurück zum Zitat Yanase T et al (2003) Sequence analysis of the medium RNA segment of three Simbu serogroup viruses, Akabane, Aino, and Peaton viruses. Virus Res 93(1):63–69PubMedCrossRef Yanase T et al (2003) Sequence analysis of the medium RNA segment of three Simbu serogroup viruses, Akabane, Aino, and Peaton viruses. Virus Res 93(1):63–69PubMedCrossRef
10.
Zurück zum Zitat Ogawa Y et al (2007) Sequence determination and functional analysis of the Akabane virus (family Bunyaviridae) L RNA segment. Arch Virol 152(5):971–979PubMedCrossRef Ogawa Y et al (2007) Sequence determination and functional analysis of the Akabane virus (family Bunyaviridae) L RNA segment. Arch Virol 152(5):971–979PubMedCrossRef
11.
Zurück zum Zitat Briese T et al (2006) Batai and Ngari viruses: M segment reassortment and association with severe febrile disease outbreaks in East Africa. J Virol 80(11):5627–5630PubMedCrossRefPubMedCentral Briese T et al (2006) Batai and Ngari viruses: M segment reassortment and association with severe febrile disease outbreaks in East Africa. J Virol 80(11):5627–5630PubMedCrossRefPubMedCentral
12.
Zurück zum Zitat Yanase T et al (2006) Genetic characterization of Batai virus indicates a genomic reassortment between orthobunyaviruses in nature. Arch Virol 151(11):2253–2260PubMedCrossRef Yanase T et al (2006) Genetic characterization of Batai virus indicates a genomic reassortment between orthobunyaviruses in nature. Arch Virol 151(11):2253–2260PubMedCrossRef
13.
Zurück zum Zitat Kobayashi T et al (2007) Genetic diversity and reassortments among Akabane virus field isolates. Virus Res 130(1–2):162–171PubMedCrossRef Kobayashi T et al (2007) Genetic diversity and reassortments among Akabane virus field isolates. Virus Res 130(1–2):162–171PubMedCrossRef
14.
Zurück zum Zitat Saeed MF et al (2001) Jatobal virus is a reassortant containing the small RNA of Oropouche virus. Virus Res 77(1):25–30PubMedCrossRef Saeed MF et al (2001) Jatobal virus is a reassortant containing the small RNA of Oropouche virus. Virus Res 77(1):25–30PubMedCrossRef
15.
Zurück zum Zitat Yanase T et al (2010) Genetic characterization of Aino and Peaton virus field isolates reveals a genetic reassortment between these viruses in nature. Virus Res 153(1):1–7PubMedCrossRef Yanase T et al (2010) Genetic characterization of Aino and Peaton virus field isolates reveals a genetic reassortment between these viruses in nature. Virus Res 153(1):1–7PubMedCrossRef
17.
Zurück zum Zitat Jones DT, Taylor WR, Thornton JM (1992) The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci 8(3):275–282PubMed Jones DT, Taylor WR, Thornton JM (1992) The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci 8(3):275–282PubMed
18.
Zurück zum Zitat Tamura K et al (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731–2739PubMedCrossRefPubMedCentral Tamura K et al (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731–2739PubMedCrossRefPubMedCentral
19.
Zurück zum Zitat Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22(22):4673–4680PubMedCrossRefPubMedCentral Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22(22):4673–4680PubMedCrossRefPubMedCentral
20.
Zurück zum Zitat Nei M, Gojobori T (1986) Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3(5):418–426PubMed Nei M, Gojobori T (1986) Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3(5):418–426PubMed
21.
22.
Zurück zum Zitat Bridgen A et al (2001) Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc Natl Acad Sci USA 98(2):664–669PubMedCrossRefPubMedCentral Bridgen A et al (2001) Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc Natl Acad Sci USA 98(2):664–669PubMedCrossRefPubMedCentral
23.
Zurück zum Zitat Muller R et al (1995) Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg 53(4):405–411PubMed Muller R et al (1995) Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg 53(4):405–411PubMed
24.
Zurück zum Zitat Varela M et al (2013) Schmallenberg virus pathogenesis, tropism and interaction with the innate immune system of the host. PLoS Pathog 9(1):e1003133PubMedCrossRefPubMedCentral Varela M et al (2013) Schmallenberg virus pathogenesis, tropism and interaction with the innate immune system of the host. PLoS Pathog 9(1):e1003133PubMedCrossRefPubMedCentral
25.
Zurück zum Zitat Briese T, Kapoor V, Lipkin WI (2007) Natural M-segment reassortment in Potosi and Main Drain viruses: implications for the evolution of orthobunyaviruses. Arch Virol 152(12):2237–2247PubMedCrossRef Briese T, Kapoor V, Lipkin WI (2007) Natural M-segment reassortment in Potosi and Main Drain viruses: implications for the evolution of orthobunyaviruses. Arch Virol 152(12):2237–2247PubMedCrossRef
26.
Zurück zum Zitat Briese T, Rambaut A, Lipkin WI (2004) Analysis of the medium (M) segment sequence of Guaroa virus and its comparison to other orthobunyaviruses. J Gen Virol 85(Pt 10):3071–3077PubMedCrossRef Briese T, Rambaut A, Lipkin WI (2004) Analysis of the medium (M) segment sequence of Guaroa virus and its comparison to other orthobunyaviruses. J Gen Virol 85(Pt 10):3071–3077PubMedCrossRef
27.
Zurück zum Zitat Pollitt E et al (2006) Characterization of Maguari orthobunyavirus mutants suggests the nonstructural protein NSm is not essential for growth in tissue culture. Virology 348(1):224–232PubMedCrossRef Pollitt E et al (2006) Characterization of Maguari orthobunyavirus mutants suggests the nonstructural protein NSm is not essential for growth in tissue culture. Virology 348(1):224–232PubMedCrossRef
28.
Zurück zum Zitat Savji N et al (2011) Genomic and phylogenetic characterization of Leanyer virus, a novel orthobunyavirus isolated in northern Australia. J Gen Virol 92(Pt 7):1676–1687PubMedCrossRefPubMedCentral Savji N et al (2011) Genomic and phylogenetic characterization of Leanyer virus, a novel orthobunyavirus isolated in northern Australia. J Gen Virol 92(Pt 7):1676–1687PubMedCrossRefPubMedCentral
29.
Zurück zum Zitat Pekosz A et al (1995) Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies. J Virol 69(6):3475–3481PubMedPubMedCentral Pekosz A et al (1995) Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies. J Virol 69(6):3475–3481PubMedPubMedCentral
30.
Zurück zum Zitat Reguera J, Weber F, Cusack S (2010) Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog 6(9):e1001101PubMedCrossRefPubMedCentral Reguera J, Weber F, Cusack S (2010) Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog 6(9):e1001101PubMedCrossRefPubMedCentral
31.
Zurück zum Zitat Elliott RM, Schmaljohn CS, Collett MS (1991) Bunyaviridae genome structure and gene expression. Curr Top Microbiol Immunol 169:91–141PubMed Elliott RM, Schmaljohn CS, Collett MS (1991) Bunyaviridae genome structure and gene expression. Curr Top Microbiol Immunol 169:91–141PubMed
33.
Zurück zum Zitat Barr JN et al (2003) Segment-specific terminal sequences of Bunyamwera bunyavirus regulate genome replication. Virology 311(2):326–338PubMedCrossRef Barr JN et al (2003) Segment-specific terminal sequences of Bunyamwera bunyavirus regulate genome replication. Virology 311(2):326–338PubMedCrossRef
34.
Zurück zum Zitat Barr JN, Wertz GW (2004) Bunyamwera bunyavirus RNA synthesis requires cooperation of 3’- and 5’-terminal sequences. J Virol 78(3):1129–1138PubMedCrossRefPubMedCentral Barr JN, Wertz GW (2004) Bunyamwera bunyavirus RNA synthesis requires cooperation of 3’- and 5’-terminal sequences. J Virol 78(3):1129–1138PubMedCrossRefPubMedCentral
35.
Zurück zum Zitat Kohl A et al (2006) Genetic elements regulating packaging of the Bunyamwera orthobunyavirus genome. J Gen Virol 87(Pt 1):177–187PubMedCrossRef Kohl A et al (2006) Genetic elements regulating packaging of the Bunyamwera orthobunyavirus genome. J Gen Virol 87(Pt 1):177–187PubMedCrossRef
36.
Zurück zum Zitat Akashi H et al (1997) Sequence determination and phylogenetic analysis of the Akabane bunyavirus S RNA genome segment. J Gen Virol 78(Pt 11):2847–2851PubMed Akashi H et al (1997) Sequence determination and phylogenetic analysis of the Akabane bunyavirus S RNA genome segment. J Gen Virol 78(Pt 11):2847–2851PubMed
37.
Zurück zum Zitat Matsumori Y et al (2002) Serological and genetic characterization of newly isolated Peaton virus in Japan. Brief report. Arch Virol 147(2):401–410PubMedCrossRef Matsumori Y et al (2002) Serological and genetic characterization of newly isolated Peaton virus in Japan. Brief report. Arch Virol 147(2):401–410PubMedCrossRef
38.
Zurück zum Zitat Lee E et al (2000) Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage In vitro is lethal for virus production. J Virol 74(1):24–32PubMedCrossRefPubMedCentral Lee E et al (2000) Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage In vitro is lethal for virus production. J Virol 74(1):24–32PubMedCrossRefPubMedCentral
39.
Metadaten
Titel
Genomic and phylogenetic characterization of Shuni virus
verfasst von
Charmaine van Eeden
Frank Harders
Jeroen Kortekaas
Alex Bossers
Marietjie Venter
Publikationsdatum
01.11.2014
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 11/2014
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-014-2131-2

Weitere Artikel der Ausgabe 11/2014

Archives of Virology 11/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.